Scott Gottlieb, MD 🇺🇸· @ScottGottliebMD · X·· 2026-06-23AI 评分22
AI 导读
👏👏 美国在开展概念验证研究方面拥有固有优势，因为优质的医疗服务是支持患者接受复杂疗法的关键，而美国在这方面做得最好 但时间和成本优势不能过度不利于美国本土试验，否则我们将失去这一优势
正文
👏👏 US has an inherent advantage in conducting proof-of-concept studies, because good medical care, to support patients receiving complex therapies, is key and US does that best
But the time and cost advantage can’t tilt so heavily against US-based trials or we’ll lose our edge
FDA, NIH officials unveil package of regulatory tweaks as more companies go elsewhere for drug research. https://on.wsj.com/4oG08Vv在 X 查看被引用的帖子
来源：Scott Gottlieb, MD 🇺🇸 · x.com